Sanofi (SNY)
48.00
+0.36
(+0.76%)
USD |
NASDAQ |
Apr 15, 16:00
48.00
0.00 (0.00%)
After-Hours: 20:00
Sanofi Research and Development Expense (Annual) : 8.845B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cellectis SA | 75.08M |
| Novavax, Inc. | 336.82M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| BioNTech SE | 2.376B |
| Moderna, Inc. | 2.917B |